Literature DB >> 17042055

The burden of ankylosing spondylitis.

Annelies Boonen1, Sjef M van der Linden.   

Abstract

The acute as well as chronic clinical features of ankylosing spondylitis (AS) are a burden to the patient and society. Apart from the axial and articular manifestations, extraarticular AS-related comorbidities such as uveitis, inflammatory bowel disease, and psoriasis contribute to the burden of the disease. In addition, a large proportion of patients have osteoporosis or osteopenia, which may be associated with fractures and contribute to kyphosis. All these features result in decreased quality of life. Moreover, patients with AS have an increased mortality rate. The impact of this disease also can be seen in various aspects of workforce participation, from requiring more assistance at paid work to withdrawal from the workforce. Further, patients with AS and, subsequently, society are affected by substantial healthcare costs related to medications and healthcare provider expenses. Early diagnosis and management of patients will likely prevent functional disability and improve patient outcomes.

Entities:  

Mesh:

Year:  2006        PMID: 17042055

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  69 in total

1.  Value of diffusion-weighted magnetic resonance imaging in early diagnosis of ankylosing spondylitis.

Authors:  Fei Ai; Tao Ai; Xiaoming Li; Daoyu Hu; Wei Zhang; John N Morelli
Journal:  Rheumatol Int       Date:  2012-01-03       Impact factor: 2.631

2.  18F-fluoride PET/CT for detection of sacroiliitis in ankylosing spondylitis.

Authors:  Klaus Strobel; Dorothee R Fischer; Giorgio Tamborrini; Diego Kyburz; Katrin D M Stumpe; Rolf G X Hesselmann; A Johayem; Gustav K von Schulthess; Beat A Michel; Adrian Ciurea
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-05-27       Impact factor: 9.236

Review 3.  Ankylosing spondylitis: A state of the art factual backbone.

Authors:  Mohammad Ghasemi-Rad; Hosam Attaya; Emal Lesha; Andrea Vegh; Tooraj Maleki-Miandoab; Emad Nosair; Nariman Sepehrvand; Ali Davarian; Hamid Rajebi; Abdolghader Pakniat; Seyed Amirhossein Fazeli; Afshin Mohammadi
Journal:  World J Radiol       Date:  2015-09-28

Review 4.  Relationship between diet and ankylosing spondylitis: A systematic review.

Authors:  Tatiana V Macfarlane; Hadeel M Abbood; Ejaz Pathan; Katy Gordon; Juliane Hinz; Gary J Macfarlane
Journal:  Eur J Rheumatol       Date:  2017-10-25

5.  Efficiency of adalimumab, etanercept and infliximab in ankylosing spondylitis in clinical practice.

Authors:  Vicente Escudero-Vilaplana; Esther Ramírez-Herráiz; Estefanía Alañón-Plaza; Nicolás Trovato-López; Rosario García-Vicuña; Luis Carreño-Pérez; Alberto Morell-Baladrón; María Sanjurjo-Sáez
Journal:  Int J Clin Pharm       Date:  2015-04-25

Review 6.  Celecoxib: a review of its use in the management of arthritis and acute pain.

Authors:  James E Frampton; Gillian M Keating
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease.

Authors:  Carmen Stolwijk; Marieke Pierik; Robert Landewé; Ad Masclee; Astrid van Tubergen
Journal:  Can J Gastroenterol       Date:  2013-04       Impact factor: 3.522

8.  Patients with ankylosing spondylitis have increased sick leave--a registry-based case-control study over 7 yrs.

Authors:  Britta Strömbeck; Lennart T H Jacobsson; Ann Bremander; Martin Englund; Anders Heide; Aleksandra Turkiewicz; Ingemar F Petersson
Journal:  Rheumatology (Oxford)       Date:  2009-01-22       Impact factor: 7.580

9.  The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people.

Authors:  Fausto Salaffi; Marina Carotti; Stefania Gasparini; Michele Intorcia; Walter Grassi
Journal:  Health Qual Life Outcomes       Date:  2009-03-18       Impact factor: 3.186

10.  Infliximab in the treatment of ankylosing spondylitis.

Authors:  Rebecca Grainger; Andrew A Harrison
Journal:  Biologics       Date:  2007-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.